Humanigen Inc (OTCMKTS:HGEN)

Humanigen Inc (OTCMKTS:HGEN)


Share Price
$ 1.14
Change
-0.008 (-0.70 %)
Market Cap
$125.88 m
Proactive Investors - Run By Investors For Investors

Humanigen Inc

www.humanigen.com

Overview

Figures in £(m) unless stated
Sales 0.000
EBITDA -11.133
Operating Profit -11.331
Pre-tax Profit -12.004
Net Profit -12.004
Capex 0.000
Operating Cash Flow -6.209
Net Working Capital -6.964
Key Ratios
EBITDA Margin 0.000
Operating Profit Margin 0.000 -%
Net Profit Margin 0.000 -%
Capex/Sales (%) 0.000
NWC/Sales (%) -
Asset Turnover 0.000
Days Inventory 0.000  days
Days Receivable 0.000  days
Days Payable 0.000  days
Performance (Last 3 Years)
Sales CAGR 0.000
EBITDA CAGR n/a
Operating Profit CAGR -
Profit CAGR -
Return on Equity(%) 0.000
Return on Assets(%) -789.737
Return on Invested Capital (ROIC)(%) 0.000
ROIC - WACC n/a
Valuation
Market Cap -
Price to Earnings 0.000
Price to Book Value 0.000
Price to Tangible Book -
Equity to FCF Yield 188.0694143167
Enterprise Value -
EV to Sales -
EV to EBITDA -
EV to Operating Profit -
EV to Invested Capital -
EV to FCF Yield -
Dividend Yield -
Payout Ratio 0
Per Share Data (in GBp unless stated)
Earnings per share -0.130000
Operating Cashflow per share -0.065525934270913
Free Cashflow per share -0.046100
Dividend per share -
NAV per share -
Cash per share -0.046100
Solvency
Intangibles Incl. Excl.
Net debt to Equity % -33.057953144266 -33.057953144266
Cash to Equity % -10.036991368681 -10.036991368681
Gross debt to Equity % -43.094944512947 -43.094944512947
Gross Debt < 1 Year to Equity -28.088779284834 -
Net debt to Assets % 255.10948905109 255.10948905109
Net Debt/EBITDA -24.081559328124 -0
Net Interest Cover -13.089202 n/a
Op Cashflow Interest Cover -7.287558685446 n/a
Current Ratio 0.157207 n/a
Quick Ratio 0.098511 n/a
Cash Ratio - n/a (Intangibles collected as non-current)
Dividend Cover - n/a
Key Dates
Latest Dividend Pay date n/a
Latest Ex-Dividend date n/a
Last Annual Results 2019-03-26
Last Interim Results 2019-03-26

Profit/Loss

Figures in £(m) unless stated31/12/1831/12/1731/12/1631/12/1531/12/1431/12/1331/12/1231/12/11
Sales 0.000---0.0000.0446.09820.255
Cost of Goods Sold ----0.0000.0000.0000.000
Gross Profit ----0.0000.0446.09820.255
Operating Expenses 11.33119.03118.82531.01736.71840.95329.58022.522
EBITDA -11.133-18.883-26.786-34.339-36.474-40.564-23.178-1.672
Depreciation & Amortisation --------
EBIT (Operating Profit) -11.331-19.031-18.825-31.017-36.718-40.909-23.482-2.267
Interest Expense/Income --0.1310.8131.1261.000--
Profit Before Tax -12.004-21.987-27.019-35.378-37.998-41.948-23.509-2.232
Taxes on Income -------0.000
Net Profit -12.004-21.987-27.019-35.378-37.998-41.948-23.509-2.232
Net Margin ------953.364-3.855-0.110
Net profit/loss per share
Basic EPS -0.130-1.470-2.780-8.570-9.200-13.840-89.760-1.360
Diluted EPS -0.130-1.470-2.780-8.570-9.200-13.840-89.760-1.360

Balance sheet

 
Figures in £(m) unless stated 31/12/1831/12/1731/12/1631/12/1531/12/1431/12/1331/12/1231/12/11
ASSETS         
Tangible Assets --------
Intangible Assets 0.0000.0000.0000.0000.0000.0000.0450.111
Investments --------
Total Fixed Assets 0.0710.1200.1690.7520.7320.9823.2830.743
Stocks --------
Debtors -------0.177
Cash & Equivalents --------
Total Current Assets 1.2991.5504.54910.39442.24577.72221.25618.604
Other Assets n/a         
Total Assets 1.3701.6704.71811.14642.97778.70424.53919.347
LIABILITIES         
Interest bearing debt < 1 year 2.27818.0183.01610.9283.182
Other Trade Creditors < 1 year --------
Total Creditors within 1 year 8.26324.6557.8240.00018.05311.3827.2178.108
Interest bearing debt > 1 year 1.2171.3511.273--6.7869.826-
Other Trade Creditors > 1 year --------
Total Creditors > 1 year 0.0000.0000.0000.0000.0000.0000.0000.000
Other Liabilities  n/a         
Total Liabilities 9.48026.0069.0975.41418.36418.168119.48391.692
Net Assets(NET Tangible Assets exist) -8.110-24.336-4.3795.73224.61360.536-94.989-72.456
EQUITY         
Called up share capital 0.1100.0150.0150.0040.0330.033102.0250.002
Share Premium 266.381238.246236.216219.319202.801200.7153.3172.412
Profit / loss -274.601-262.597-240.610-213.591-178.213-140.215-98.267-74.758
Other Equity 0.0000.0000.0000.000-0.0080.003-204.042-0.001
Shareholders Funds -8.110-24.336-4.3795.73224.61360.536-196.967-72.345
Preference Stock ------102.023-
Total Capital Employed -8.110-24.336-4.3795.73224.61360.536-94.944-72.345

Cash flow

Figures in £(m) unless stated 31/12/1831/12/1731/12/1631/12/1531/12/1431/12/1331/12/1231/12/11
EBITDA -12.004-21.987-27.019-35.378-37.998-41.948-23.509-2.232
Change in Working Capital 0.2552.6231.570-2.609-1.0650.806-1.596-14.391
Cash Taxes Paid --------
Cash Interest Paid/Received --------
Other (incl. non-cash items) --------
Net Cash from Operating Activities -6.209-14.249-20.961-29.063-35.939-38.815-23.906-15.330
Capital Expenditure ----0.136-0.448-0.344-0.020-0.463
Acquisitions/Disposals --------
Other Investing Activities --------
Net Cashflow from Investing Activities 0.0000.0000.10330.097-8.220-13.9205.0759.732
Dividends --------
Increase/Decrease in Debt 3.47512.0805.191-3.4520.7890.0009.8400.000
Increase/Decrease in Equity 2.781-10.1328.2190.07397.5300.0840.034
Other Financing Activities 0.000-0.010-8.2930.000-1.52216.5160.000
Cash from Financing 6.25612.08015.333-3.5260.86296.00826.4400.034
Net increase in cash 0.047-2.169-5.525-2.492-43.29743.2737.609-5.564

Directors dealings

Date Director Trans Amount Type Price(p) Value (£) Holding %
2018-09-28 Mr. Robert G. Savage - 24219.00 Common Stock, $0.001 par value 64 - 65219.00
2018-09-28 Mr. Ronald Barliant - 21094.00 Common Stock, $0.001 par value 64 - 141880.00
2018-09-28 Mr. Rainer Boehm, M.B.A.,M.D. - 21094.00 Common Stock, $0.001 par value 64 - 48094.00
2018-08-07 Mr. Robert G. Savage - 31000.00 Common Stock, $0.001 par value 50 - 41000.00
2018-08-07 Mr. Ronald Barliant - 27000.00 Common Stock, $0.001 par value 50 - 120786.00
2018-08-07 Mr. Rainer Boehm, M.B.A.,M.D. - 27000.00 Common Stock, $0.001 par value 50 - 27000.00
- Mr. Robert G. Savage - 0.00 Common Stock, $0.001 par value 0 - 10000.00
2018-03-09 Mr. Robert G. Savage - 715877 Stock Option (Right to Buy) 0 - 715877.00
2018-03-09 Timothy E. Morris - 88235 Stock Option (Right to Buy) 0 - 88235.00
2018-03-09 Timothy E. Morris - 715877 Stock Option (Right to Buy) 0 - 715877.00
2018-03-09 Dr. Cameron Durrant - 7466749 Stock Option (Right to Buy) 0 - 8509771.00
2018-03-09 Mr. Ronald Barliant - 715877 Stock Option (Right to Buy) 0 - 715877.00
2018-03-09 Mr. Ronald Barliant - 156863 Stock Option (Right to Buy) 0 - 156863.00
2018-03-09 Mr. Greg Jester - 1073815 Stock Option (Right to Buy) 0 - 1223815.00
2018-03-09 Mr. Greg Jester - 284313 Stock Option (Right to Buy) 0 - 284313.00
2018-03-09 Mr. Rainer Boehm, M.B.A.,M.D. - 715877 Stock Option (Right to Buy) 0 - 715877.00
2018-02-27 Mr. Dale Chappell - 32028669.00 Common Stock, $0.001 par value 9.37 - 46876309.00
2018-02-27 Mr. Dale Chappell - 12812322.00 Common Stock, $0.001 par value 0 - 14847640.00
2018-02-27 Mr. Dale Chappell - 11957369.00 Common Stock, $0.001 par value 0 - 13997832.00
2018-02-27 Mr. Dale Chappell - 5123733.00 Common Stock, $0.001 par value 0 - 5996710.00
2017-02-21 David L. Tousley - 100000 Employee Stock Option (right to buy) 0 - 100000.00
2017-02-21 Mr. Morgan Lam - 100000 Employee Stock Option (right to buy) 0 - 100000.00
2016-09-13 Timothy E. Morris - 100000 Stock Option (right to buy) 0 - 100000.00
2016-09-13 Cameron Durrant - 1043022 Stock Option (right to buy) 0 - 1043022.00
2016-09-13 Mr. Ronald Barliant - 100000 Stock Option (right to buy) 0 - 100000.00
- Mr. Morgan Lam - 0 Employee Stock Option (right to buy) 0 - 0.00
2016-09-13 Mr. Morgan Lam - 100000 Stock Option (right to buy) 0 - 100000.00
- Mr. Dale Chappell - 0.00 Common Stock, par value $0.001 0 - 2040463.00
- Mr. Dale Chappell - 0.00 Common Stock, par value $0.001 0 - 2035318.00
- Mr. Dale Chappell - 0.00 Common Stock, par value $0.001 0 - 872977.00
2016-09-13 Mr. Dale Chappell - 100000 Stock Option (Right to Buy) 0 - 100000.00
2016-09-13 Mr. Ezra M. Friedberg - 100000 Stock Option (right to buy) 0 - 100000.00
2016-08-25 Mr. Martin Shkreli - 1913206.00 Common Stock 310 - 309723.00
2016-08-26 Mr. Martin Shkreli - 309723.00 Common Stock 310 - 0.00
2016-06-30 Cameron Durrant - 135583.00 Common Stock 0 - 135583.00
2016-06-30 Mr. Ronald Barliant - 93786.00 Common Stock 0 - 93786.00
- Mr. Dale Chappell - 0.00 Common Stock, par value $0.001 0 - 872977.00
- Mr. Dale Chappell - 0.00 Common Stock, par value $0.001 0 - 2035318.00
- Mr. Dale Chappell - 0.00 Common Stock, par value $0.001 0 - 2040463.00

Dividends

Temporarily not available. Please try again later.
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use